The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause

Endokrynologia Polska

Volumn 57, Issue 1, 2006, Pages 15-22

  Siemiñska, Lucyna ^a   Wojciechowska, Celina ^a   Foltyn, Wanda ^a   Kajdaniuk, Dariusz ^a   Kos Kudła, Beata ^a   Marek, Bogdan ^a   Nasiek, Maja ^b   Nowak, Mariusz ^a   Strzelczyk, Janusz ^a   Zemczak, Anna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Endocrinological Clinic Gliwice   (Poland)

Author keywords

Adiponectin; Leptin; Menopause; Metabolic syndrome

Indexed keywords

ADIPONECTIN; LEPTIN;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SECRETION;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LEPTIN; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE;

EID: 34248520490     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barrett-Connor E. Epidemiology and the menopause: a global overview. Int J Fertil Menopausal Stud 1993; 38: 6-14. (Pubitemid 24058667)
2. Piche ME, Weisnagel SJ, Corneau L et al. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 2005; 54: 770-777. (Pubitemid 40322081)
3. Matsuzawa Y, Funahashi T, Nakamura T Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adi-pocyte-derived bioactive substances. Ann N Y Acad Sci 1999; 892: 146-154.
4. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. (Pubitemid 32472900)
5. Hotta K, Funahashi T, Arita Y et al. Plasma concentration of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599. (Pubitemid 30353893)
6. Van Harmelen V, Reynisdottir S, Eriksson P et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998; 47: 913-917. (Pubitemid 28255665)
7. Gower BA, Nagy TR, Goran MI et al. Leptin in postmenopau-sal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 2000; 85: 1770-1775. (Pubitemid 32269274)
8. Leyva F, Godsland IF, Ghatei M et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928-933. (Pubitemid 28272587)
9. Milewicz A, Zatonska K, Demissie M et al. Serum adiponectin concentration and cardiovascular risk factors in climacteric women. Gynecol Endocrinol 2005; 20: 68-73. (Pubitemid 40604020)
10. Tufano A, Marzo P, Enrini R et al. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. Endocrinol Invest 2004; 27: 648-653. (Pubitemid 39359827)
11. Nishizawa H, Shimomura I, Kishida K et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-deri-ved protein. Diabetes 2002; 51: 2734-2741. (Pubitemid 34970926)
12. Milewicz A, Bidzinska B, Mikulski E et al. Influence of obesity and menopausal status on serum leptin, cholecystokin, gala-nin and neuropeptide Y levels. Gyneol Endocrinol 2000; 14: 196-203. (Pubitemid 30449897)
13. Sieminska L, Wojciechowska C, Niedziołka D et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism 2005; 54: 1610-1614. (Pubitemid 41728152)
14. Gavrila A, Chan JL, Yiannakouris N et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003; 88: 4823-4831. (Pubitemid 37357532)
15. Grundy SM, Brewer HB, Cleeman IL i wsp. Definition of the metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to the Definition. Circulation 2004; 109: 433-438. (Pubitemid 38133916)
16. Colombel A, Charbonnel B. Weight gain and cardiovascular risk factors in the postmenopausal women. Hum Reprod 1997; 1: 134-145.
17. Calles-Escandon J, Arciero PJ, Gardner AW et al. Basal fat oxidation decreases with aging in women. J Appl Physiol 1995; 78: 266-271.
18. Ross R, Fortier L, Hudson R. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care 1996; 19: 1404-1411. (Pubitemid 26418623)
19. Klein S. The case of visceral fat: argument for the defense. J Clin Invest 2004; 113: 1530-1532. (Pubitemid 39071675)
20. Abate N, Haffner SM, Garg A et al. Sex steroid hormones, upper body obesity and insulin resistance. J Clin Endocrinol Me-tab 2002; 87: 4522-4527. (Pubitemid 35247035)
21. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-1585. (Pubitemid 27411233)
22. Van Pelt RE, Evans EM, Schechtman KB et al. Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 2002; 282: E1023-E1028. (Pubitemid 34654715)
23. Snijder MB, Visser M, Dekker JM et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005; 48: 301-308. (Pubitemid 40543303)
24. Staiger H, Tschritter O, Machann J et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003; 11: 368-372. (Pubitemid 41151622)
25. Adamczak M, Wiecek A, Funahashi T et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003;16: 72-75. (Pubitemid 36078595)
26. Ouchi N, Kihara S, Arita Y et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063. (Pubitemid 32200177)
27. Xydakis AM, Case CC, Jones PH et al. Adiponectin, inflammation and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004; 89: 2697-2703. (Pubitemid 38766352)
28. von Eynatten M, Schneider JG, Humpert PM et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: association independent of systemic inflammation and insulin resistance. Diabetes Care 2004; 27: 2925-2929. (Pubitemid 39565060)
29. Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes 2003; 52: 2121-2128. (Pubitemid 36919807)
30. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147: 173-180.
31. Satoh N, Naruse M, Usui T et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004; 27: 2488-2490. (Pubitemid 39281406)
32. Lindheim SR, Buchanan TA, Duffy DM et al. Comparison of estimates of insulin sensitivity in premenopausal and postme-nopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gy-necol Invest 1994; 1: 150-154. (Pubitemid 2107006)
33. Sites CK, Toth MJ, Cushman M et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002; 77: 128-135. (Pubitemid 34093904)
34. Piemonti L, Calori G, Mercalli A et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemo-attracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003; 26: 2883-2889. (Pubitemid 37205563)
35. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999; 13: 1231-1238. (Pubitemid 29300368)
36. Yamagishi S, Edelstein D, Du X et al. Leptin induces mitochon-drial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 27: 25096-25100.